iloprost and Myalgia

iloprost has been researched along with Myalgia* in 1 studies

Other Studies

1 other study(ies) available for iloprost and Myalgia

Article	Year
Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiency. BMJ case reports, 2019, Jan-03, Volume: 12, Issue:1 Selective immunoglobulin M deficiency (sIgMD) is an immunodeficiency with undefined pathogenesis and commonly presenting with recurrent infections. Topics: Adult; Aftercare; Antirheumatic Agents; Autoimmune Diseases; Humans; Hydroxychloroquine; Iloprost; Immunoglobulin G; Immunoglobulin M; Immunologic Deficiency Syndromes; Infusions, Intravenous; Male; Mixed Connective Tissue Disease; Myalgia; Nifedipine; Synovitis; Treatment Outcome; Vasodilator Agents	2019

Article

Year

Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiency.

BMJ case reports, 2019, Jan-03, Volume: 12, Issue:1

Selective immunoglobulin M deficiency (sIgMD) is an immunodeficiency with undefined pathogenesis and commonly presenting with recurrent infections.

Topics: Adult; Aftercare; Antirheumatic Agents; Autoimmune Diseases; Humans; Hydroxychloroquine; Iloprost; Immunoglobulin G; Immunoglobulin M; Immunologic Deficiency Syndromes; Infusions, Intravenous; Male; Mixed Connective Tissue Disease; Myalgia; Nifedipine; Synovitis; Treatment Outcome; Vasodilator Agents

2019